Entresto may reduce AF recurrence after ablation in some patients
CHICAGO — Compared with valsartan, sacubitril/valsartan was linked to reduced risk for atrial tachyarrhythmia recurrence after catheter ablation for atrial fibrillation, according to the results of the SUPERIOR trial.
For the SUPERIOR trial, presented at the American Heart Association Scientific Sessions, Wei Zhang, MD, PhD, cardiologist in the department of cardiovascular medicine at the Shanghai Institute of Hypertension at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, and colleagues enrolled 320 patients aged 55 to 79 years with AF and high blood pressure who